Colon cancer cell lines; Podocalyxin like protein 1 (Podocalyxin 1) fragment; Serum free cultured (SFC) medium; Surface enhanced laser desorption ionization time of flight mass spectrometry (SELDI TOF MS)
Indexed keywords
MONOCLONAL ANTIBODY;
PODOCALYXIN;
ARTICLE;
CANCER CELL CULTURE;
CELL DIFFERENTIATION;
COLON CANCER;
CONTROLLED STUDY;
HUMAN;
HUMAN CELL;
IMMUNOBLOTTING;
IMMUNOPRECIPITATION;
POLYACRYLAMIDE GEL ELECTROPHORESIS;
PROTEIN ANALYSIS;
PROTEIN DEGRADATION;
SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;
Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin
Kershaw D.B., Beck S.G., Wharram B.L., Wiggins J.E., Goyal M., Thomas P.E., et al. Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin. J Biol Chem 272 (1997) 15708-15714
The intramembrane cleavage site of the amyloid precursor protein depends on the length of its transmembrane domain
Lichtenthaler S.F., Beher D., Grimm H.S., Wang R., Shearman M.S., Masters C.L., et al. The intramembrane cleavage site of the amyloid precursor protein depends on the length of its transmembrane domain. Proc Natl Acad Sci U S A 99 (2002) 1365-1370
Possible presence of an embryonal carcinoma-associated proteoglycan in the serum of patients with testicular germ cell tumours
Mason M.D., Pera M.F., and Cooper S. Possible presence of an embryonal carcinoma-associated proteoglycan in the serum of patients with testicular germ cell tumours. Eur J Cancer 27 (1991) 300
Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells
Pera M.F., Blasco-Lafita M.J., Cooper S., Mason M., Mills J., Monaghan P., et al. Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells. Differentiation 39 (1988) 139-149
Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines
Sasaki K., Sato K., Akiyama Y., Yanagihara K., Oka M., Yamaguchi K., et al. Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines. Cancer Res 62 (2002) 4894-4898
Mass spectrometric high-throughput analysis of serum-free conditioned medium from cancer cell lines
Sato K., Sasaki K., Akiyama Y., Yamaguchi K., et al. Mass spectrometric high-throughput analysis of serum-free conditioned medium from cancer cell lines. Cancer Lett 170 (2001) 153-159
Peptide differential display of serum-free conditioned medium from cancer cell lines
Sato K., Sasaki K., Tsao M.S., Yamaguchi K., et al. Peptide differential display of serum-free conditioned medium from cancer cell lines. Cancer Lett 176 (2002) 199-203
Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment γ
Yu C., Kim S.H., Ikeuchi T., Xu H., Gasparini L., Wang R., et al. Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment γ. J Biol Chem 276 (2001) 43756-43760
